... the idea behind this is PRECISELY to STOP scams like DECN run by crooks like Keith Berman from suckering in more marks because of their inability to comply with the requirements.
But only those actually CAPABLE of meeting the requriements WILL become Pink/ Current again. The rest - those who for reasons of probity or simlar can't - including DECN - will fail. And that is rather the point.
I correctly called the DECN Tall oaks patent litigation against JnJ WAY before that was concluded. I correctly called the Genviro scam, way before the suspension and subsequent criminal indictments. Go look. The evidence is there. Its not hard to find! So my track record on DECN related predictions is not too shabby, taken in the round.
Now I don't know what precisely it is that YOU are trying to teach ME here? But you will have to excuse me if I pass up your lessons, and continue to trust MY OWN knowledge, information and judgement when it comes to matters DECN related. I am sure there are many others who could have or actually have saved themselves significant pain and losses by doing likewise! And furthermore there are many who have endured significant avoidable losses by listening to those who instead made completely unfounded predictions about the imminent success of this scam company! e.g suggesting 6x stock increases or similar multiples. JUST SAYING!
The above relates to two different unconnected issues!
Filing a current quarterly report does not automatically make the company "Pink Current". OTC Markets makes the decision to remove the Caveat Emptor designation, with a current report not being the sole qualification. Keep in mind, DECN has posted quarterly reports, since being suspended by the SEC, but the Caveat Emptor designation remains. The Attorney Letter has no bearing on the CE situation! It is simply a normal procedure for those choosing to file an annual financial report, using the Alternative Reporting Standard.
The scramble caused by the SEC is specifically related to the new SEC disclosure amendment that was delivered last September. It has nothing to do with being Caveat Emptor. The new SEC Disclosure Rule is specific to ANY OTC company, Pink or otherwise, which is deemed delinquent in reporting Material Events and quarterly financial information. A current financial report does not remove the CE designation, but it does remove the SEC's disclosure scrutiny.